Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Boston Scientific Corp shares valued at $4,923,327 were sold by Fitzgerald Joseph Michael on Oct 01 ’25. At $98.47 per share, Fitzgerald Joseph Michael sold 50,000 shares. The insider’s holdings dropped to 178,342 shares worth approximately $17.09 million following the completion of this transaction.
Also, JOSEPH M FITZGERALD purchased 50,000 shares, netting a total of over 4,923,325 in proceeds.
Before that, Fitzgerald Joseph Michael had sold 50,000 shares from its account. In a trade valued at $5,271,416, the EVP & Group Pres, Cardiology traded Boston Scientific Corp shares for $105.43 each. Upon closing the transaction, the insider’s holdings decreased to 50,000 shares, worth approximately $17.09 million.
As published in a research note from Oppenheimer on September 08, 2025, Boston Scientific Corp [BSX] has been rated up from a Perform to an Outperform and the price target has been revised to $125. Analysts at Leerink Partners started covering the stock with ‘”an Outperform”‘ outlook in a report released in mid June. As of April 16, 2025, Needham has increased its “Hold” rating to a “Buy” for BSX. Earlier on January 10, 2025, Deutsche Bank upgraded its rating. Their new recommendation was “a Buy” for BSX stock which previously was a “a Hold”.
Analyzing BSX Stock Performance
On last trading session, Boston Scientific Corp [NYSE: BSX] plunged -1.82% to $95.85. The stock’s lowest price that day was $90.69, but it reached a high of $99.01 in the same session. During the last five days, there has been a drop of approximately -2.25%. Over the course of the year, Boston Scientific Corp shares have jumped approximately 15.00%. Shares of the company reached a 52-week high of $109.50 on 09/09/25 and a 52-week low of $85.98 on 04/07/25.
Support And Resistance Levels for Boston Scientific Corp (BSX)
According to the 24-hour chart, there is a support level at 91.36, which, if violated, would cause prices to drop to 86.86. In the upper region, resistance lies at 99.68. The next price resistance is at 103.50. RSI (Relative Strength Index) is 27.79 on the 14-day chart, showing oversold technical sentiment.
Is Boston Scientific Corp subject to short interest?
Stocks of Boston Scientific Corp saw a sharp rise in short interest on 2025-09-15 jumping by 0.41 million shares to 19.02 million. Data from Yahoo Finance shows that the short interest on 2025-08-15 was 18.6 million shares. A jump of 2.16% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 2.76 of the overall float, the days-to-cover ratio (short ratio) jumped to 2.76.
Which companies own the most shares of Boston Scientific Corp (BSX)?
In terms of Boston Scientific Corp share price expectations, FactSet research, analysts set an average price target of 128 in the next 12 months, up nearly 31.11% from the previous closing price of $97.63. Analysts anticipate Boston Scientific Corp stock to reach 132 by 2025, with the lowest price target being 118. In spite of this, 15 analysts ranked Boston Scientific Corp stock as Buy at the end of 2025.
